TWST: Barclays Raises PT
Barclays maintains overweight rating on Twist Bioscience and raises price target to $95
Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $95
Barclays maintains overweight rating on Twist Bioscience and raises price target to $95
Barclays Maintains Overweight on Twist Bioscience, Raises Price Target to $95